RadNet, Inc. (RDNT) Form 8-K — Nov 9, 2026
RadNet reported record third-quarter results, with revenue up 22.1% to $638.3 million and Adjusted EBITDA up 23.8% to $105.0 million versus Q3 2025. Adjusted diluted EPS came in at $0.30 versus $0.24 a year ago, while GAAP net income attributable to common stockholders was $4.2 million ($0.05 diluted). Growth was broad-based: aggregate advanced imaging volumes (MRI, CT, PET/CT) rose 19.9% and same-center advanced imaging volumes rose 8.9% year over year, lifting advanced imaging to 30.6% of total procedures. The Digital Health segment grew revenue 32.6% to $32.9 million, though its Adjusted EBITDA declined 11.8% to $3.0 million amid continued investment in DeepHealth Cloud OS and AI.
Key figures
- Eps
- 0.3
- Revenue
- 638300000
- Guidance
- Imaging Center segment FY2026 raised: Total Net Revenue $2,385-$2,435M, Adjusted EBITDA $350-$363M, Free Cash Flow $120-$130M; Digital Health Adjusted EBITDA before non-capitalized R&D raised to $11-$13M
- Net Income
- 4153000
- Total Assets
- 4280398000
- Cash Position
- 750600000
- Shares Outstanding
- 78768800
- Ct volume growth
- 22.0%
- Mri volume growth
- 18.3%
- Gaap diluted eps q3
- 0.05
- Pet ct volume growth
- 30.4%
- Adjusted ebitda margin
- 16.5%
- Adjusted ebitda q3 2026
- 105044000
- Digital health revenue q3
- 32900000
- Nine month revenue growth
- 23.1%
- Adjusted ebitda yoy growth
- 23.8%
- Net debt to adjusted ebitda
- 1.66x
- Weighted avg diluted shares
- 79174226
- Digital health revenue growth
- 32.6%
- Adjusted diluted eps prior year
- 0.24
- Digital health adjusted ebitda change
- -11.8%
- Aggregate advanced imaging volume growth
- 19.9%
- Same center advanced imaging volume growth
- 8.9%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.